Kilitch Drugs (India) Share Price
181.14+8.62 (+5.00%)
+1.66% past 1 Year
Kilitch Drugs (India) Limited is an India-based company engaged in pharmaceutical business. The Company’s services range from manufacturing to marketing a host of formulations in all dosage forms such as
Corporate filings & documents
Announcements
We are submitting herewith the scrutinizers report for the voting process of 34th Annual General Meeting of Kilitch Drugs India Limited
1 week agoWe are submitting herewith the scrutinizers report for the voting process of 34th Annual General Meeting of Kilitch Drugs India Limited
1 week agoWe are submitting herewith the proceeding of 34th Annual General Meeting
1 week agoWe are submitting herewith the proceeding of 34th Annual General Meeting
1 week agoWe are submitting herewith the monitoring agency report
2 weeks agoWe are submitting herewith the publication of extract of the financial results for the quarter ended 30th June 2026
2 weeks agoSubmission of financial results for the quarter ended 30th June 2026
3 weeks agoSubmission of financial results for the quarter ended 30th June 2026
3 weeks agoWe are submitting herewith the financial results for the quarter ended 30th June 2026
3 weeks agoWe are submitting herewith the financial results for the quarter ended 30th June 2026
3 weeks agoKilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended 30th June 2026
3 weeks agoKilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve unaudited standalone and consolidated financial results for the quarter ended 30th June 2026
3 weeks agoWe are submitting herewith the copy of the newspaper publication of extract of AGM Notice
1 month agoWe are submitting herewith the copy of the newspaper publication of extract of AGM Notice
1 month agoWe are submitting the copy of Physical intimation made to the shareholders whose email address was not registered
1 month agoWe are submitting the copy of Physical intimation made to the shareholders whose email address was not registered
1 month agoWe are submitting the intimation of Book Closure
1 month agoWe are submitting the intimation of Book Closure
1 month agoWe are submitting herewith the annual report for the FY 2025-26
1 month agoWe are submitting herewith the annual report for the FY 2025-26
1 month agoWe are hereby submitting the notice of Annual General Meeting schedule to be held on Thursday 27th August 2026
1 month agoWe are hereby submitting the notice of Annual General Meeting schedule to be held on Thursday 27th August 2026
1 month agoOutcome of board meeting is enclosed for ready reference
1 month agoOutcome of board meeting is enclosed for ready reference
1 month agoWe are submitting herewith the certification under regulation 74(5) of SEBI (DP) Regulations
1 month agoWe are submitting herewith the certification under regulation 74(5) of SEBI (DP) Regulations
1 month agoWe are submitting herewith the intimation of Closure of window
2 months agoWe are submitting herewith the intimation of Closure of window
2 months agoWe are pleased to inform you that we have commenced the Nutraceutical Manufacturing Block of our new plant located at 24/2/1/1 Maldev Pen Raigad Maharashtra India today. i.e 17th June 2026
2 months agoWe are pleased to inform you that we have commenced the Nutraceutical Manufacturing Block of our new plant located at 24/2/1/1 Maldev Pen Raigad Maharashtra India today. i.e 17th June 2026
2 months agoWe are hereby submitting annual secretarial compliance report for the year ended 31st March 2026
3 months agoWe are submitting hereby copy of newspaper publication of the extract of financial results for the quarter ended 31st March 2026
3 months agoWe are submitting hereby copy of newspaper publication of the extract of financial results for the quarter ended 31st March 2026
3 months agoWe are hereby submitting audited standalone and consolidated financial results of the Company for the quarter ended 31st March 2026
3 months agoWe are hereby submitting audited standalone and consolidated financial results of the Company for the quarter ended 31st March 2026
3 months agoWe are hereby submitting audited standalone and consolidated financial results for the quarter ended 31st March 2026
3 months agoWe are hereby submitting audited standalone and consolidated financial results for the quarter ended 31st March 2026
3 months agoWe are hereby submitting the monitoring agency report for the quarter ended 31st March 2026
3 months agoWe are hereby submitting the monitoring agency report for the quarter ended 31st March 2026
3 months agoKilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended 31st March 2026
4 months agoKilitch Drugs India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 inter alia to consider and approve the audited financial results (standalone and consolidated) of the Company for the quarter and year ended 31st March 2026
4 months agoWe are hereby submitting certificate under regulation 74(5) of SEBI (DP) Regulations received from MUFG Intime India Private Limited RTA of the Company
4 months agoWe are hereby submitting certificate under regulation 74(5) of SEBI (DP) Regulations received from MUFG Intime India Private Limited RTA of the Company
4 months agoBoard approved the allotment of bonus equity shares in the ratio of 1:1
5 months agoClosure of Trading Window
5 months agoWe hereby inform you that the Company has fixed Tuesday 24th March 2026 as record date in order to determine the number of shareholders entitled for bonus equity shares in the ratio of 1:1
5 months agoWe hereby inform you that the Company has fixed Tuesday 24th March 2026 as record date in order to determine the number of shareholders entitled for bonus equity shares in the ratio of 1:1
5 months agoWe are submitting herewith the Scrutinizers Report
5 months agoWe are submitting herewith the Scrutinizers Report
5 months agoWe hereby submit proceeding of EGM
5 months agoAnnual reports
Corporate Actions
Date
Type
Details
2026-03-24
Bonus
1:1
2025-07-15
Rights
2:23;357.0 (Rights ratio;Offer price)
2019-09-20
Dividend
0.5
2018-09-18
Dividend
0.5
2012-09-24
Dividend
30.0
2011-08-18
Dividend
1.0
2010-10-14
Dividend
1.0
Company details
Registered office
C 301/2 M I D C T T C Industrial Area Pawane Village Navi Mumbai Maharashtra PIN: 400705 Tel No: 022-62996300 Fax No: 022-27680912 Email: [email protected] Internet: www.kilitch.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Mukund Mehta, Managing Director
Mira Mehta, Managing Director
Bhavin Mehta, Whole Time Director
Vasudev Krishnamurti, Non Executive Independent Director
V S Rajan, Non Executive Independent Director
Dipen J Jain, Non Executive Independent Director
Pushpa Nyoupane, Company Secretary & Compliance Officer
Details
BSE 524500
NSE KILITCH
ISIN INE729D01010